Crystalline forms of fingolimod HCL

Details for Australian Patent Application No. 2009315736 (hide)

Owner Novartis AG

Inventors Mutz, Michael; Jordine, Guido

Agent Davies Collison Cave

Pub. Number AU-A-2009315736

PCT Pub. Number WO2010/055028

Priority 08168865.7 11.11.08 EP

Filing date 10 November 2009

Wipo publication date 20 May 2010

International Classifications

C07C 215/28 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/055028 Priority application(s): WO2010/055028

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009315753-Device for covering a surface

2009315735-Salts of fingolimod